Changes in lipoprotein(a) following bariatric surgery.
作者信息
Lin Bing-Xue, Weiss Matthew C, Parikh Manish, Berger Jeffrey S, Fisher Edward A, Heffron Sean P
机构信息
Department of Medicine, Leon H. Charney Division of Cardiology, New York University Langone Medical Center, New York University School of Medicine, New York, NY.
Department of Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY.
出版信息
Am Heart J. 2018 Mar;197:175-176. doi: 10.1016/j.ahj.2017.10.020. Epub 2017 Nov 4.
Abstract
摘要
相似文献
1
Changes in lipoprotein(a) following bariatric surgery.减肥手术后脂蛋白(a)的变化。
Am Heart J. 2018 Mar;197:175-176. doi: 10.1016/j.ahj.2017.10.020. Epub 2017 Nov 4.
2
Endocrine changes (beyond diabetes) after bariatric surgery in adult life.成人生活中减肥手术后的内分泌变化（糖尿病以外）。
J Endocrinol Invest. 2013 Apr;36(4):267-79. doi: 10.3275/8880. Epub 2013 Feb 27.
3
Bariatric Surgery: The Future of Obesity Management in Adolescents.减重手术：青少年肥胖管理的未来
Adv Pediatr. 2017 Aug;64(1):269-283. doi: 10.1016/j.yapd.2017.03.005.
4
Addiction Transfer and Other Behavioral Changes Following Bariatric Surgery.减重手术后的成瘾转移和其他行为变化。
Surg Clin North Am. 2021 Apr;101(2):323-333. doi: 10.1016/j.suc.2020.12.005.
5
Effects of bariatric surgery in different obesity phenotypes: Tehran Obesity Treatment Study (TOTS).不同肥胖表型的减重手术效果：德黑兰肥胖治疗研究（TOTS）。
Obes Surg. 2020 Feb;30(2):461-469. doi: 10.1007/s11695-019-04182-y.
6
The role of malabsorption in bariatric surgery.吸收不良在减肥手术中的作用。
World J Surg. 2009 Oct;33(10):1989-94. doi: 10.1007/s00268-009-0101-8.
7
Modification of cardiometabolic profile in obese diabetic patients after bariatric surgery: changes in cardiovascular risk.减重手术后肥胖糖尿病患者心脏代谢指标的改变：心血管风险的变化
Rev Esp Cardiol (Engl Ed). 2013 Oct;66(10):812-8. doi: 10.1016/j.rec.2013.05.018. Epub 2013 Aug 2.
8
Comment on: Three-year weight outcomes from a bariatric surgery registry in a large integrated healthcare system.评论：大型综合医疗系统中减肥手术登记处的三年体重结果。
Surg Obes Relat Dis. 2014 May-Jun;10(3):403-4. doi: 10.1016/j.soard.2014.03.006. Epub 2014 Mar 14.
9
Resting Energy Expenditure and Metabolic Adaptation in Adolescents at 12 Months After Bariatric Surgery.减肥手术后 12 个月青少年的静息能量消耗和代谢适应。
J Clin Endocrinol Metab. 2019 Jul 1;104(7):2648-2656. doi: 10.1210/jc.2018-02244.
10
American Society for Metabolic and Bariatric Surgery updated position statement on sleeve gastrectomy as a bariatric procedure.美国代谢与减重外科学会关于袖状胃切除术作为一种减重手术的最新立场声明。
Surg Obes Relat Dis. 2017 Oct;13(10):1652-1657. doi: 10.1016/j.soard.2017.08.007. Epub 2017 Aug 22.
引用本文的文献
1
Initial decrease in the lipoprotein(a) level is a novel prognostic biomarker in patients with acute coronary syndrome.脂蛋白(a)水平的初始降低是急性冠状动脉综合征患者的一种新型预后生物标志物。
World J Cardiol. 2024 Jun 26;16(6):329-338. doi: 10.4330/wjc.v16.i6.329.
2
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024.肥胖、血脂异常与心血管疾病：肥胖医学协会和国家脂质协会2024年联合专家综述
Obes Pillars. 2024 Mar 12;10:100108. doi: 10.1016/j.obpill.2024.100108. eCollection 2024 Jun.
3
The Effect of Bariatric Surgery on Circulating Levels of Lipoprotein (a): A Meta-analysis.减重手术对脂蛋白（a）循环水平的影响：一项荟萃分析。
Biomed Res Int. 2022 Aug 17;2022:8435133. doi: 10.1155/2022/8435133. eCollection 2022.
4
Circulating Lipoproteins in Subjects with Morbid Obesity Undergoing Bariatric Surgery with Gastric Bypass or Sleeve Gastrectomy.病态肥胖患者在接受胃旁路手术或袖状胃切除术进行减肥手术后的循环脂蛋白。
Nutrients. 2022 Jun 8;14(12):2381. doi: 10.3390/nu14122381.
5
Therapeutic management of hyperlipoproteinemia (a).高脂蛋白血症（a）的治疗管理
Drugs Context. 2019 Sep 4;8:212609. doi: 10.7573/dic.212609. eCollection 2019.
本文引用的文献
1
Bile acids and bariatric surgery.胆汁酸与减肥手术
Mol Aspects Med. 2017 Aug;56:75-89. doi: 10.1016/j.mam.2017.04.001. Epub 2017 Apr 17.
2
Effects of bariatric surgery on hepatic and intestinal lipoprotein particle metabolism in obese, nondiabetic humans.减重手术对肥胖非糖尿病患者肝脏和肠道脂蛋白颗粒代谢的影响。
Arterioscler Thromb Vasc Biol. 2014 Oct;34(10):2330-7. doi: 10.1161/ATVBAHA.114.303849. Epub 2014 Aug 7.
3
[Effect of biliary obstruction on lipoprotein(a) concentration].
Clin Investig Arterioscler. 2014 Sep-Oct;26(5):218-23. doi: 10.1016/j.arteri.2014.01.003. Epub 2014 Mar 13.
4
AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: an analysis from the LDL-C Assessment with Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined with Statin Therapy (LAPLACE)-Thrombolysis in Myocardial Infarction (TIMI) 57 trial.AMG145，一种针对前蛋白转化酶枯草溶菌素 9 的单克隆抗体，可显著降低接受他汀类药物治疗的高胆固醇血症患者的脂蛋白(a)：来自 LDL-C 评估与前蛋白转化酶枯草溶菌素 9 单克隆抗体抑制联合他汀类药物治疗（LAPLACE）-心肌梗死溶栓治疗（TIMI）57 试验的分析。
Circulation. 2013 Aug 27;128(9):962-9. doi: 10.1161/CIRCULATIONAHA.113.001969. Epub 2013 Jul 24.
5
New therapeutic principles in dyslipidaemia: focus on LDL and Lp(a) lowering drugs.血脂异常的新治疗原则：重点关注 LDL 和 Lp(a)降低药物。
Eur Heart J. 2013 Jun;34(24):1783-9. doi: 10.1093/eurheartj/eht088. Epub 2013 Mar 18.
6
Farnesoid X receptor represses hepatic human APOA gene expression.法尼醇 X 受体抑制肝脏人载脂蛋白 A 基因的表达。
J Clin Invest. 2011 Sep;121(9):3724-34. doi: 10.1172/JCI45277. Epub 2011 Aug 1.
Zotero 插件